Share Issue News

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and inflammatory diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted 2 new employees options to purchase a total of 9,150 shares of the Company’s common stock at an exercise price per share of $23.83, which was the closing pric...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were appr...

BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund’s initial public offering in November 2009. The fourth-quarter distribution of $0.4625 per share is equal to a quarterly rate of 0.8601% (3.44% annualized) of the...

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today the pricing of an underwritten public offering of 2,000,000 shares of its 9.25% Series B Cumulative Redeemable Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), at a price of $25.00 per share, for gross proceeds of $50,000,000. The Company granted the underwriters of the offering a 30-day option to purchase up to an additional 300,000 shares of the Company’...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--RiverNorth Capital and Income Fund, Inc. (the “Fund”) (NYSE: RSF), a closed-end fund, announced the final results of its repurchase offer for up to 5% of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on October 7, 2026. Based on information provided by DST Systems, Inc., the depositary for the repurchase offer, a total of 1,202,757 shares were submitted for redemption and 173,168 shares were repurchased. In accordan...

NEW YORK--(BUSINESS WIRE)--Better Home & Finance Holding Company (NASDAQ: BETR) (“Better” or the “Company”) today announced that its Board of Directors authorized the repurchase of up to $30 million of the Company’s Class A common stock. Better intends to begin repurchases with an initial $10 million phase. The program advances Better 2.0’s commitment to disciplined capital allocation as Better advances its next phase of growth. The Company intends to align the pace of the repurchases with...

HOUSTON--(BUSINESS WIRE)--Crescent Energy Company (“Crescent” or the “Company”) (NYSE: CRGY) today announced the commencement of an underwritten public offering of $1,000,000,000 of its Class A common stock, par value $0.0001 per share (“Class A common stock”), pursuant to an effective shelf registration statement on Form S-3 (the “Registration Statement”) filed previously with the U.S. Securities and Exchange Commission (the “SEC”). The Company intends to use the net proceeds it receives from...

CHICAGO--(BUSINESS WIRE)--Nuveen Municipal Credit Opportunities Fund (NYSE: NMCO) (the “Fund”) today announced the preliminary results of its transferable rights offering (the “Offer”) which expired at 5:00 p.m., Eastern time, on October 7, 2026 (the “Expiration Date”). The Offer entitled the rights holders to subscribe for additional common shares of the Fund (“Common Shares”). The Offer is expected to result in the issuance of approximately 13.7 million Common Shares (including notices of gua...

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today that it has commenced a public offering of its Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”). The Company expects to grant the underwriters a 30-day option to purchase additional shares to cover overallotments, if any. Currently no market exists for the Series B Preferred Stock. The Company plans to file an application to list the Series B Preferred Stock...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage target oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 120,900 shares of common stock and 7,200 restricted stock units (“...